Brookfield Corp
DCPH icon

Brookfield Corp’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Brookfield Corp’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-71,874
Closed -$1.33M – 769
2022
Q3 		$1.33M Buy
+71,874
New +$1.13M ﹤0.01% 510

Other funds holding DCPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Polar Capital Holdings
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Brookfield Corp's DCPH Position: Q4 2022 in Review

Brookfield Corp sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2022, closing a stake of 71,874 shares — an estimated $1.33M sold.

Brookfield Corp first reported a position in DCPH in Q3 2022 and held it in 1 quarter. The position peaked at $1.33M in Q3 2022. 143 funds tracked by Wall St. Rank hold DCPH as of Q4 2022.

  • Brookfield Corp reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Brookfield Corp sold 71,874 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $1.33M.
  • Brookfield Corp first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Brookfield Corp's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.33M in Q3 2022.
  • 143 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.